IN2014DN01468A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN01468A IN2014DN01468A IN1468DEN2014A IN2014DN01468A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A IN 1468DEN2014 A IN1468DEN2014 A IN 1468DEN2014A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A
- Authority
- IN
- India
- Prior art keywords
- oligosaccharide
- composition
- infants
- mixture
- probiotic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000008133 cognitive development Effects 0.000 abstract 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 230000008132 psychomotor development Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pediatric Medicine (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 | ||
| PCT/EP2012/070281 WO2013057049A1 (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01468A true IN2014DN01468A (OSRAM) | 2015-05-22 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1468DEN2014 IN2014DN01468A (OSRAM) | 2011-10-18 | 2012-10-12 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (OSRAM) |
| EP (2) | EP3095331A1 (OSRAM) |
| CN (1) | CN103889238B (OSRAM) |
| AU (1) | AU2012325060B2 (OSRAM) |
| BR (1) | BR112014008944B1 (OSRAM) |
| CL (1) | CL2014000759A1 (OSRAM) |
| ES (1) | ES2601891T3 (OSRAM) |
| IN (1) | IN2014DN01468A (OSRAM) |
| MX (1) | MX350435B (OSRAM) |
| MY (1) | MY170185A (OSRAM) |
| PH (1) | PH12014500443A1 (OSRAM) |
| PL (1) | PL2775852T3 (OSRAM) |
| PT (1) | PT2775852T (OSRAM) |
| RU (1) | RU2607458C2 (OSRAM) |
| WO (1) | WO2013057049A1 (OSRAM) |
| ZA (1) | ZA201403591B (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| DK2708147T3 (da) | 2012-09-14 | 2020-05-18 | Abbott Lab | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose |
| EP2708145B1 (en) | 2012-09-14 | 2016-05-04 | Abbott Laboratories | Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals |
| EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
| RU2016129426A (ru) * | 2013-12-19 | 2018-01-24 | Нестек С.А. | Питательная композиция для снижения метаболического стресса у младенцев |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| AU2015340652B9 (en) * | 2014-10-31 | 2020-04-16 | Société des Produits Nestlé S.A. | Composition comprising Fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
| US20170354696A1 (en) * | 2014-11-26 | 2017-12-14 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
| US10857167B2 (en) | 2015-04-28 | 2020-12-08 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| ES2772685T3 (es) * | 2015-08-04 | 2020-07-08 | Nestle Sa | Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes |
| PT3389404T (pt) | 2015-12-15 | 2020-01-14 | Nestle Sa | Mistura de hmos |
| CN108697142A (zh) * | 2016-01-26 | 2018-10-23 | 雀巢产品技术援助有限公司 | 用于控制婴儿或幼儿的食物摄入量和生长的包含2FL和LNnT的组合物 |
| WO2017129641A1 (en) * | 2016-01-26 | 2017-08-03 | Nestec S.A. | Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth |
| US10925906B2 (en) | 2016-04-13 | 2021-02-23 | Meiji Co., Ltd. | Composition for improving brain function for neonates |
| RU2019105567A (ru) | 2016-07-28 | 2020-08-28 | Фонтерра Ко-Оперэйтив Груп Лимитед | Молочный продукт и способ |
| KR102724343B1 (ko) | 2017-05-04 | 2024-11-04 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 신경발달-촉진 식품 조성물 및 이와 관련된 키트, 시스템 및 방법 |
| ES2955524T3 (es) | 2017-05-16 | 2023-12-04 | Ability Pharmaceuticals S A | Una combinación farmacéutica para el tratamiento de un cáncer |
| WO2018215406A1 (en) * | 2017-05-24 | 2018-11-29 | Nestec S.A. | A nutritional composition for use to enhance attention and/or reduce impulsivity |
| WO2019008104A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
| CN111093395A (zh) * | 2017-07-07 | 2020-05-01 | 雀巢产品有限公司 | 人乳强化剂 |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| US20230414640A1 (en) | 2020-12-04 | 2023-12-28 | Societe Des Produits Nestle S.A. | Stable aqueous composition for preterm to promote early postnal growth |
| KR102570073B1 (ko) * | 2022-11-17 | 2023-08-24 | (주)에이피테크놀로지 | 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물 |
| CN118285505A (zh) * | 2024-03-29 | 2024-07-05 | 黑龙江飞鹤乳业有限公司 | 促进大脑发育的营养组合物、食品及配方奶粉 |
| WO2025257135A1 (en) | 2024-06-10 | 2025-12-18 | N.V. Nutricia | Non-digestible oligosaccharide mixture for infants at risk of brain injury |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| ES2416287T3 (es) * | 2003-06-23 | 2013-07-31 | Nestec S.A. | Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal |
| ATE433674T1 (de) * | 2003-06-23 | 2009-07-15 | Nestec Sa | Säuglingsnährpräparat oder folgemilch |
| MXPA05010349A (es) * | 2003-06-30 | 2006-03-08 | Clasado Inc | Composicion novedosa de galactooligosacaridos y preparacion de la misma. |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| ATE468027T1 (de) * | 2006-02-10 | 2010-06-15 | Nestec Sa | Oligosaccharidmischung |
| CA2644968A1 (en) * | 2006-03-07 | 2007-09-13 | Nestec S.A. | Synbiotic mixture |
| US20080003330A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| EP2224826B1 (en) * | 2007-11-26 | 2018-12-26 | Nestec S.A. | Age-tailored nutrition system for infants |
| WO2010115935A1 (en) * | 2009-04-07 | 2010-10-14 | Glycom A/S | Synthesis of 2 ' -o-fucosyllactose |
| EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2258216A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| CN102481323A (zh) * | 2009-07-31 | 2012-05-30 | 雀巢产品技术援助有限公司 | 含有益生菌和所选营养物的用于母乳喂养的婴幼儿或宠物的营养组合物 |
| CN102803282A (zh) | 2010-02-19 | 2012-11-28 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
| BR112013031086A2 (pt) * | 2011-06-08 | 2016-11-29 | Nestec Sa | composições nutricionais tendo componentes de membrana de glóbulo de gordura de leite exógenos |
-
2012
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en not_active Ceased
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 PH PH1/2014/500443A patent/PH12014500443A1/en unknown
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014119844A (ru) | 2015-11-27 |
| ZA201403591B (en) | 2016-01-27 |
| CN103889238A (zh) | 2014-06-25 |
| BR112014008944A2 (pt) | 2017-05-02 |
| EP3095331A1 (en) | 2016-11-23 |
| US20140271562A1 (en) | 2014-09-18 |
| WO2013057049A1 (en) | 2013-04-25 |
| MX350435B (es) | 2017-09-06 |
| PT2775852T (pt) | 2016-11-08 |
| MX2014004716A (es) | 2015-02-05 |
| PL2775852T3 (pl) | 2017-02-28 |
| RU2607458C2 (ru) | 2017-01-10 |
| AU2012325060A1 (en) | 2014-03-13 |
| BR112014008944B1 (pt) | 2020-09-15 |
| CN103889238B (zh) | 2017-10-13 |
| AU2012325060B2 (en) | 2015-11-19 |
| MY170185A (en) | 2019-07-09 |
| CL2014000759A1 (es) | 2014-08-22 |
| EP2775852B1 (en) | 2016-08-17 |
| EP2775852A1 (en) | 2014-09-17 |
| PH12014500443A1 (en) | 2014-04-14 |
| ES2601891T3 (es) | 2017-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN01468A (OSRAM) | ||
| PH12012501823A1 (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
| PH12014500509B1 (en) | Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery | |
| PH12014500558A1 (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| PH12013501892A1 (en) | Nutritional compositions including branched chain fatty acids for wound healing | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| WO2013049519A3 (en) | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols | |
| BR112012023328A2 (pt) | composições nutricionais | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| PH12016500690A1 (en) | Probiotic stabilization | |
| BR112013028820A2 (pt) | alimento medicinal para declínio cognitivo | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| HK1201067A1 (en) | Sialic acid analogs | |
| WO2011088209A3 (en) | 1-deoxy analogs of vitamin d-related compounds | |
| PH12013502563A1 (en) | Dha and epa in the reduction of oxidative stress | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| NZ709741A (en) | Improvement of cognitive function in preterm infants that are small for gestational age | |
| GB201209344D0 (en) | Omega-6 enriched pufa phospholipids | |
| MX358142B (es) | Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. | |
| MX2015013179A (es) | Formula infantil con bajo contenido calorico que contiene acido beta-hidroxi-beta-metilbutirico. | |
| PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych | |
| UA52520U (ru) | Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста |